Simone Pellizzeri
Overview
Explore the profile of Simone Pellizzeri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malagola M, Castagna L, Farina M, Pellizzeri S, Degrandi E, Oldani E, et al.
Leuk Lymphoma
. 2025 Jan;
1-4.
PMID: 39813626
No abstract available.
2.
Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study
Tiecco G, De Francesco M, Lenzi A, Pellizzeri S, Rossini F, Sollima A, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Nov;
44(1):99-107.
PMID: 39527170
Background And Purpose: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infections worldwide, with hypervirulent strains linked to severe disease and higher mortality. This study aims to analyze...
3.
Russo D, Polverelli N, Bernardi S, Santarone S, Farina M, Borlenghi E, et al.
Lancet Haematol
. 2024 Sep;
11(11):e830-e838.
PMID: 39312920
Background: Access to allogeneic haematopoietic stem-cell transplantation (HSCT) remains challenging for older patients (aged >60 years) with acute myeloid leukaemia. We aimed to evaluate the efficacy of venetoclax plus decitabine...
4.
Farina M, Scaini M, Facchinetti A, Leoni A, Bernardi S, Catoni C, et al.
Transplant Cell Ther
. 2024 Apr;
30(6):580.e1-580.e14.
PMID: 38582286
Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), is a rare but potentially fatal complication following allogenic hematopoietic cell transplantation (allo-HCT). Timely identification of SOS/VOD to allow for...
5.
Malagola M, Iurlo A, Bucelli C, Abruzzese E, Bonifacio M, Stagno F, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Feb;
24(5):323-331.
PMID: 38369436
Background: Intermittent treatment with tyrosine kinase inhibitors (TKIs) is an option for elderly chronic myeloid leukemia (CML) patients who are often candidates for life-long treatment. Materials And Methods: The Italian...
6.
Malagola M, Radici V, Farina M, Pellizzeri S, Spoldi F, Morello E, et al.
Bone Marrow Transplant
. 2023 Nov;
59(2):293.
PMID: 38030882
No abstract available.
7.
Morello E, Brambilla G, Bernardi S, Villanacci V, Carlessi M, Farina M, et al.
Transpl Immunol
. 2023 Nov;
81:101954.
PMID: 37931667
Malnutrition in allogeneic stem cell transplant (allo-SCT) is associated with poor outcomes. Supplementation with Foods for Special Medical Purposes may be a valid alternative to enteral nutrition or total parental...
8.
Malagola M, Radici V, Farina M, Pellizzeri S, Spoldi F, Morello E, et al.
Bone Marrow Transplant
. 2023 Oct;
59(1):138-140.
PMID: 37857841
No abstract available.
9.
De Francesco M, Piva S, Pellizzeri S, Signorini L, Fumarola B, Corbellini S, et al.
J Med Virol
. 2023 Oct;
95(10):e29192.
PMID: 37855669
No abstract available.
10.
De Francesco M, Signorini L, Piva S, Pellizzeri S, Fumarola B, Corbellini S, et al.
J Med Virol
. 2023 Jul;
95(7):e28892.
PMID: 37394790
Patients with viral infections are at higher risk to acquire bacterial and fungal superinfections associated with a worse prognosis. We explored this critical point in the setting of patients with...